PhEED, a new RCT for post ischemic or hemorrhagic stoke patients with dysphagia has started enrollment in the US and Europe

Pharyngeal Electrical Stimulation Evaluation for Dysphagia after Stroke (PhEED) is a prospective multi-centre randomised controlled single-blinded trial with Non-Significant Risk status granted by FDA.

If you are a healthcare professional working in an acute rehab center and are interested in being part of PhEED in US, please contact Nadine Juran at nadine.juran@phagenesis.com.

For more information click here.